Technical Analysis for ARCH - Arch Biopartners Inc

Grade Last Price % Change Price Change
F 1.190 0.00% 0.000
ARCH closed down 3.25 percent on Tuesday, September 26, 2023, on 1.58 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.25%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Gap Up Closed about 2 hours ago
Gap Up Partially Closed about 2 hours ago
Reversed from Up about 2 hours ago
Fell Below Previous Day's Low about 2 hours ago
2x Volume Pace about 2 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Arch Biopartners Inc Description

Arch Biopartners Inc. is a portfolio-based biotechnology company. The Company is focused on the development of technologies that make a medical or commercial impact. Its technology platforms include AB569, MetaBlok, Arch Inflammation, Borg and MetaMx. AB569 is a drug candidate for treating antibiotic resistant bacterial infections, primarily in the lungs and urinary tract. MetaBlok is a drug candidate targeting sepsis, cancer metastasis and inflammation based diseases. Arch Inflammation is a treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. Arch Inflammation is focused on developing anti-inflammatory small molecules that target proteins in the innate immune system. Borg is a peptide-solid surface Interface for binding of peptides to solid metal and plastic surfaces to inhibit biofilm formation. MetaMx are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The Company has not generated any revenues.


Sector: Healthcare
Industry: Biotechnology
Keywords: Metal Health Medicine Drug Biotechnology Disease Cancer Diseases Plastic Bacteria Immunology Proteins Tumor Infection Peptide Antibiotic Immune System Inflammation Biofilm Peptides Brain Brain Tumor Chronic Kidney Infections Technology Platforms

Is ARCH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.32
52 Week Low 1.18
Average Volume 26,064
200-Day Moving Average 2.181
50-Day Moving Average 1.790
20-Day Moving Average 1.511
10-Day Moving Average 1.435
Average True Range 0.080
RSI (14) 15.25
ADX 57.74
+DI 5.686
-DI 44.193
Chandelier Exit (Long, 3 ATRs) 1.431
Chandelier Exit (Short, 3 ATRs) 1.419
Upper Bollinger Bands 1.756
Lower Bollinger Band 1.266
Percent B (%b) -0.15
BandWidth 32.455
MACD Line -0.133
MACD Signal Line -0.111
MACD Histogram -0.0225
Fundamentals Value
Market Cap 72.33 Million
Num Shares 60.8 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -32.16
Price-to-Sales 601.44
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.310
Resistance 3 (R3) 1.320 1.290 1.290
Resistance 2 (R2) 1.290 1.259 1.285 1.283
Resistance 1 (R1) 1.240 1.241 1.225 1.230 1.277
Pivot Point 1.210 1.210 1.203 1.205 1.210
Support 1 (S1) 1.160 1.179 1.145 1.150 1.103
Support 2 (S2) 1.130 1.161 1.125 1.097
Support 3 (S3) 1.080 1.130 1.090
Support 4 (S4) 1.070